Edition:
United States

People: Arrowhead Pharmaceuticals Inc (ARWR.O)

ARWR.O on Nasdaq

1.44USD
2 Dec 2016
Change (% chg)

$0.12 (+9.09%)
Prev Close
$1.32
Open
$1.40
Day's High
$1.48
Day's Low
$1.33
Volume
6,306,249
Avg. Vol
1,334,607
52-wk High
$8.22
52-wk Low
$1.32

Given, Douglas 

Dr. Douglass B. Given M.D., Ph.D., MBA is a Chairman of the Board and Director of Arrowhead Research Corp. He has been a director of the company since November 2010. Dr. Given is the founder and managing partner of G5 Partners LLC and Director and Chief Executive Officer of Health 2047, Inc., a San Francisco, California based health information start up. He joined Bay City Capital, LLC in 2000, served as a General Partner and Investment Partner from 2004-2014, and participated in more than 50 investments. He has co-founded 14 startup companies. He formerly held positions as Corporate Senior Vice President and Chief Technology Officer at Mallinckrodt, Vice President at Schering Plough, Vice President at Monsanto/GD Searle and Medical Advisor at Lilly. He has been a Director at 8 public and 8 private companies and is currently Chairman at Arrowhead, Vivaldi Biosciences Inc and Medical eXellence Inc. He has held positions as CEO at Progenitor Inc, Mercator Genetics Inc, NeoRx Corp, VIA Pharmaceuticals Inc, and Vivaldi Biosciences Inc. Dr. Given has been a member of the University of Chicago Medical Center and Pritzker School of Medicine Visiting Committee since 1995 and served as its Chair from 2007-2013. He received his MD & PhD from the University of Chicago and MBA from the Wharton School, University of Pennsylvania

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Douglas Given

--

Christopher Anzalone

2,319,760

Kenneth Myszkowski

1,074,100

Bruce Given

2,128,870

David Lewis

863,439

Peter Leone

679,669
As Of  29 Sep 2015